HomeAbout

TL;DR CNBC


The end of the Covid health emergency won't slow FDA clearance of shots and treatments - TL;DR CNBC

The end of the Covid health emergency won't slow FDA clearance of shots and treatments

Publishing timestamp: 2023-01-31 13:32:32


Summary

The FDA said that the end of the public health emergency will not impact its ability to authorize Covid vaccines, tests and treatments on an emergency basis. The FDA has used its emergency powers to authorize vaccines from Pfizer, Moderna, Johnson & Johnson and Novavax, as well as other treatments and tests. The FDA also proposed new lead limits for baby food to reduce potential risks to children's health.


Sentiment: NEUTRAL

Tickers: PFEMRNAJNJNVAX

Keywords: coronaviruspandemicsbiotechnologyepidemicsnovavax incdisease outbreaksmoderna incbusinessu.s. economypfizer incbreaking news: businesshealth care industrybiotech and pharmaceuticalsjohnson & johnsonpoliticsbusiness newsjoe biden

Source: https://www.cnbc.com/2023/01/31/covid-fda-clearance-of-covid-shots-and-treatments-wont-slow-with-end-of-public-health-emergency.html


Developed by Leo Phan